Outcome of adjuvant radiotherapy after radical prostatectomy for prostate cancer patients

Urologia Internationalis

Volumn 84, Issue 4, 2010, Pages 382-387

  Suzuki, Kazumi ^a   Nakano, Kazuhiko ^a   Morita, Tatsuo ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Adjuvant radiotherapy; Biochemical failure; Prostate cancer; Radical prostatectomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BIOCHEMICAL FAILURE FREE SURVIVAL; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL FAILURE FREE SURVIVAL; DISEASE FREE SURVIVAL; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERINEURIUM; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; RADIATION DOSE; SEMINAL VESICLE; SURVIVAL TIME; ADJUVANT THERAPY; BLOOD; CANCER STAGING; CHI SQUARE DISTRIBUTION; JAPAN; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; PROSTATIC NEOPLASMS; RISK ASSESSMENT; RISK FACTOR; TIME; TREATMENT OUTCOME; TUMOR INVASION;

AGED; CHI-SQUARE DISTRIBUTION; HUMANS; JAPAN; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77953218947     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000296288     Document Type: Article

References (27)

1. Cancer Registration Committee of the Japanese Urological Association: Clinicopathological statistics on registered prostate cancer patients in Japan: 2000 report from the Japanese Urological Association. Int J Urol 2005; 12: 46-61.
2. Watson RB, Civantos F, Soloway MS: Positive surgical margins with radical prostatectomy: detailed pathological analysis and prognosis. Urology 1996; 48: 80-90.
3. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Tamaszewski JE, Wein A: Prostate- specific antigen failure despite pathologically organ-confined and margin-negative prostate cancer: the basis for an adjuvant therapy trial. J Clin Oncol 1997; 15: 1465-1469.
4. Pound CR, Partin AW, Einsenberger MA, Chan DW, Pearson JD, Walsh PC: Natural history of progression after PSA elevation following radical prostatectomy. JAMA 1999; 281: 1591-1597.
5. Wadasaki K, Kaneyasu Y, Kenjo M, Matsuura K, Murakami Y, Hashimoto Y, Ito K, Kiriu H, Ito A: Treatment results of adjuvant radiotherapy and salvage radiotherapy after radical prostatectomy for prostate cancer. Int J Clin Oncol 2007; 12: 37-41.
6. Teh BS, Bastasch MD, Mai W-Y, Kattan MW, Butler B, Kadmon D: Long-term benefits of elective radiotherapy after prostatectomy for patients with positive surgical margins. J Urol 2006; 175: 2097-2102.
7. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, Tomaszewski JE, Renshaw AA, Kaplan I, Beard CJ, Wein A: Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998; 280: 969-974. (Pubitemid 28445094)
8. Cox JD, Stetz J, Pajak TF: Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31: 1341-1346.
9. Valicenti RK, Ghervoneva I, Gomella LG: Importance of margin extent as a predictor of outcome after adjuvant radiotherapy for Gleason score 7 pT3N0 prostate cancer. Int J Radiat Oncol Biol Phys 2004; 58: 1093-1097.
10. Petrovich Z, Lieskovsky G, Langholz B, Formenti S, Baert L, Streeter O, Skinner DG: Radical prostatectomy and postoperative irradiation in patients with pathological stage C (T3) carcinoma of the prostate. Int J Radiat Oncol Biol Phys 1998; 40: 139-147.
11. Petrovich Z, Lieskovsky G, Langholz B, Bochner B, Formenti S, Streeter O, Skinner DG: Adjuvant radiotherapy in patients with pathological stage C (pT3N0) adenocarcinoma of the prostate. Urology 1999; 53: 1184-1193.
12. Valicenti RK, Gomella LG, Ismail M, Strup SE, Mulholland SG, Dicker AP, Petersen RO, Newschaffer CJ: The efficacy of early adjuvant radiation therapy for pT3N0 prostate cancer: a matched-pair analysis. Int J Radiat Oncol Biol Phys 1999; 45: 53-58.
13. Leibovich BC, Engen DE, Patterson DE, Pisansky TM, Alexander EE, Blute ML, Bergstralh EJ, Zincke H: Benefit of adjuvant radiation therapy for localized prostate cancer with a positive surgical margin. J Urol 2000; 163: 1178-1182.
14. Catton C, Gospodarowicz M, Warde P, Panzarella T, Catton P, McLean M, Milosevic M: Adjuvant and salvage radiation therapy after radical prostatectomy for adenocarcinoma of the prostate. Radiother Oncol 2001; 59: 51-60.
15. Petrovich Z, Lieskovsky G, Langholz B, Jozsef G, Streeter O, Skinner DG: Postoperative radiotherapy in 423 patients with pT3N0 prostate cancer. Int J Radiat Oncol Biol Phys 2002; 53: 600-609.
16. Kamat AM, Babaian K, Chung MR, Naya Y, Huang SH, Kuban D, Babaian RJ: Identification of factors predicting response to adjuvant radiation therapy in patients with positive margins after radical prostatectomy. J Urol 2003; 170: 1860-1863.
17. Tayler N, Kelly JF, Kuban DA, Babaian RJ, Pisters LL, Pollack A: Adjuvant and salvage radiotherapy after radical prostatectomy for prostate cancer. Int J Radiat Oncol Biol Phys 2003; 56: 755-763.
18. Cheng L, Jones TD, Lin H, Eble JN, Zeng G, Carr MD, Koch MO: Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma. J Urol 2005; 174: 2181-2185.
19. Yu HH, Song DY, Tsai YY, Thompson T, Frassica DA, DeWeese TL: Perineural invasion affects biochemical recurrence-free survival in patients with prostate cancer treated with definitive external beam radiotherapy. Urology 2007; 70: 111-116.
20. Beard C, Schultz D, Loffredo M, Cote K, Renshaw AA, Hurwitz MD, D'Amico AV: Perineural invasion associated with increased cancer-specific mortality after external beam radiation therapy for men with low- and intermediate-risk prostate cancer. Int J Radiat Oncol Biol Phys 2006; 66: 403-407.
21. Ng JC, Koch MO, Daggy JK, Cheng L: Perineural invasion in radical prostatectomy specimens: lack of prognostic significance. J Urol 2004; 172: 2249-2251.
22. Lee IH, Roberts R, Shah RB, Wojno KJ, Wei JT, Sandler HM: Perineural invasion is a marker for pathologically advanced disease in localized prostate cancer. Int J Radiat Oncol Biol Phys 2007; 68: 1059-1064.
23. Salmon L, Anastasiadis AG, Johnson CW, McKiernan JM, Goluboff ET, Abbou CC, Olsson CA, Benson MC: Seminal vesicle involvement after radical prostatectomy: predicting risk factors for progression. Urology 2003; 62: 304-309.
24. Bolla M, van Poppel H, Collette L, van Cangh P, Vekemans K, Da Pozzo L, de Reijke TM, Verbaeys A, Bosset JF, van Velthoven R, Marechal JM, Scalliet P, Haustermans K, Pierart M, European Organization for Research and Treatment of Cancer: Postoperative radiotherapy after radical prostatectomy: a randomized controlled trial (EORTC trial 22911). Lancet 2005; 366: 13-19.
25. Swanson GP, Thompson LM, Tangen C, Miller G, Lucia MS, Troyer DA, Paradelo J, Chin JL, Messing EM, Canby-Higano E, Crawford DE: Phase III randomized study of adjuvant radiation therapy versus observation in patients with pathologic T3 prostate cancer (SWOG 8794). Int J Radiat Oncol Biol Phys Suppl 2005; 63:S1.
26. Wiegel T, Bottke D, Willich N, Piechota HJ, Souchon R, Stoeckle M, Ruebe C, Hinke A, Hinkelbein W, Miller K: Phase III results of adjuvant radiotherapy versus 'wait and see' in patients with pT3 prostate cancer following radical prostatectomy (ARO96-02/AUO AP 09/95). J Clin Oncol 2005; 23(suppl): 4513.
27. Thompson IM, Tangen CM, Paradelo J, Lucia MS, Miller G, Troyer D, Messing E, Forman J, Chin J, Swanson G, Canby-Higano E, Crawford ED: Adjuvant radiotherapy for pathologically advanced prostate cancer. JAMA 2006; 296: 2329-2335.